Dr. Jakob Langer works in Novo Nordisk Inc., Plainsboro, NJ, USA, is a well-known researcher in field of Internal Medicine. One of his renowned work is Comparative Real World Effectiveness of Liraglutide versus Sitagliptin in Patients with Type 2 Diabetes as an Add-On to Metformin Monotherapy in the United States